article Open AccessTop 1% cited
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
Clinical Infectious Diseases · 2016 · Vol. 63(4) · pp. e1–e60
Thomas F. Patterson✉(The University of Texas Health Science Center at San Antonio)George R. Thompson(University of California, Davis)David W. Denning(University of Manchester)Jay A. Fishman(Massachusetts General Hospital)Susan Hadley(Tufts Medical Center)Raoul Herbrecht(Université de Strasbourg)Dimitrios P. Kontoyiannis(The University of Texas MD Anderson Cancer Center)Kieren A. Marr(Sidney Kimmel Comprehensive Cancer Center)Vicki A. Morrison(Hennepin County Medical Center)M. Hong Nguyen(University of Pittsburgh)Brahm H. Segal(Roswell Park Comprehensive Cancer Center)William J. Steinbach(Duke Medical Center)David A. Stevens(California Institute for Medical Research)Thomas J. Walsh(Cornell University)John R. Wingard(University of Florida)Jo‐Anne H. Young(University of Minnesota System)John E. Bennett(National Institutes of Health)
Abstract
It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. IDSA considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient's individual circumstances.
Antifungal resistance and susceptibilityFungal Infections and StudiesNeutropenia and Cancer InfectionsMedicineAspergillosisIntensive care medicineFamily medicineImmunology
MeSH terms
Amphotericin BAntifungal AgentsAspergillosisAzolesHumansSocieties, MedicalUnited StatesEchinocandinsInfectious Disease Medicine
Funding
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
Citations
2,733
FWCI
169.51
field-weighted impact
References
679
Percentile
100%
vs. same field & year
Citations per year
Cited by
Infection in Organ Transplantation
American Journal of Transplantation · 2017 · 773 citations
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
The Lancet Infectious Diseases · 2020 · 928 citations
References
THE SPECTRUM OF THE DISEASE IN 98 PATIENTS
Medicine · 1970 · 987 citations
Chronic Granulomatous Disease: Report on a National Registry of 368 Patients
Medicine · 2000 · 1,712 citations
Aspergillosis Case-Fatality Rate: Systematic Review of the Literature
Clinical Infectious Diseases · 2001 · 1,416 citations
Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
Journal of Antimicrobial Chemotherapy · 2013 · 680 citations
Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database
Clinical Infectious Diseases · 2010 · 1,422 citations
Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia
The American Journal of Medicine · 1982 · 868 citations
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
Clinical Infectious Diseases · 2008 · 2,688 citations
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
Clinical Infectious Diseases · 2011 · 3,380 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.